TrialDrugs in R&D2022

Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions.

Hong-Yu Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.